Psychoneuroimmunology
Psychoneuroimmunoly (PNI) takes an interdisciplinary approach, incorporating psychology, neuroscience, immunology, physiology, genetics, pharmacology, molecular biology, psychiatry, behavioral medicine, infectious diseases, endocrinology, and rheumatology. The main interests of PNI are the interactions between the nervous and immune systems and the relationships between mental processes and health. PNI studies, among other things, the physiological functioning of the neuroimmune system in
health and disease; disorders of the neuroimmune system (autoimmune diseases; hypersensitivities; immune deficiency); and the physical, chemical and physiological characteristics of the components of the neuroimmune system. There are now sufficient data to conclude that immune modulation by psychosocial stressors and/or interventions can lead to actual
health changes. Although changes related to
infectious disease and wound healing have provided the strongest evidence to date, the clinical importance of immunological dysregulation is highlighted by increased risks across diverse conditions and diseases. For example, stressors can produce profound
health consequences. In one epidemiological study, all-cause mortality increased in the month following a severe stressor – the death of a spouse. Theorists propose that stressful events trigger cognitive and affective responses which, in turn, induce sympathetic nervous system and endocrine changes, and these ultimately impair immune function. Potential
health consequences are broad, but include rates of infection, HIV progression,
cancer incidence and progression and high rates of infant mortality.
High Impact List of Articles
-
Is there a role for palliative care in reducing emergency department use by older adults?
GN Thompson
Editorial: Clinical Practice
-
Is there a role for palliative care in reducing emergency department use by older adults?
GN Thompson
Editorial: Clinical Practice
-
An overview of satavaptan: a selective V2 receptor antagonist
Jareer Farah, Suleiman Daifallah, Hammam Zmily and Jalal K Ghali
Drug Evaluation: Clinical Practice
-
An overview of satavaptan: a selective V2 receptor antagonist
Jareer Farah, Suleiman Daifallah, Hammam Zmily and Jalal K Ghali
Drug Evaluation: Clinical Practice
-
Efficacy, safety and tolerability of orlistat,a lipase inhibitor, in the treatment of adolescent weight excess
Roberto Bogarin and Jean-Pierre Chanoine
Drug Evaluation: Clinical Practice
-
Efficacy, safety and tolerability of orlistat,a lipase inhibitor, in the treatment of adolescent weight excess
Roberto Bogarin and Jean-Pierre Chanoine
Drug Evaluation: Clinical Practice
-
New theory on HIV spread
News and Views: Clinical Practice
-
New theory on HIV spread
News and Views: Clinical Practice
-
The obesity pandemic
L Romayne Kurukulasuriya and James R Sowers
Editorial: Clinical Practice
-
The obesity pandemic
L Romayne Kurukulasuriya and James R Sowers
Editorial: Clinical Practice
Relevant Topics in Clinical